Clinical Trial Update: Comparison of Yuxintine With Placebo in Treatment of MDD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing Yuxintine with placebo for major depressive disorder. Sponsor: Shanghai Mental Health Center; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Yuxintine

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Major Depressive Disorder (MDD) | Phase 2 | Status: UNKNOWN